drugs Class II Updated 2014-03-12

Teva Pharmaceuticals USA recalls Teva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bo

Recalled Product

Teva Hydroxyzine Pamoate Capsules, USP, 25 mg, 100- count bottle, Rx Only,Distributed by Teva Pharmaceuticals, USA, Sellersville, PA. NDC 0555-0323-02.


Hazard / Issue

CGMP Deviations: Hydroxyzine Pamoate Capsules, USP, 25 mg were manufactured using an unapproved material: API was incorrectly released for use in manufacturing.

Issued by

FDA

Distribution: Nationwide (United States)
Lot/Code Info: Lot # 34016752A, Exp. 09/16. Lot # 34016753A, Exp. 09/16.
View official government recall

Looking for safe alternatives?

Browse certified-safe products in this category on Amazon →